Research Article
Genome-Wide Prediction of Vaccine Candidates for Leishmania major: An Integrated Approach
Table 5
The distribution of fractional immunogenicity for the 45 optimal epitopes against the population of North Africa.
| S. number | Epitope | Fraction of overall immunogenicity | Covered alleles |
| 1 | SLWSLLAGV | 0.09 | A0201 | 2 | YMDPGAAGY | 0.09 | A0101 | 3 | YLLDGDQLI | 0.07 | A0201 | 4 | TPRIPLDSL | 0.05 | B0702 B0801 B3501 | 5 | LPRLFLAFL | 0.05 | B0702 B0801 B3501 | 6 | FIDANTAIY | 0.05 | A0101 | 7 | VESGALFSF | 0.04 | B4403 | 8 | VLVGVVLGV | 0.04 | A0201 | 9 | TLFPIDVTV | 0.04 | A0201 | 10 | ELRRRGQEV | 0.04 | B0801 | 11 | GYPNINTYL | 0.03 | A2402 | 12 | LYLLLPFLL | 0.03 | A2402 | 13 | LMAAMLVAV | 0.03 | A0201 | 14 | FPISKGAAL | 0.03 | B0702 B0801 B3501 | 15 | FLFSPTDTL | 0.03 | A0201 | 16 | GYIVVDKYF | 0.03 | A2402 | 17 | MLPDMTCSL | 0.02 | A0201 | 18 | SLFRVANCK | 0.02 | A0301 | 19 | APAAPHSPL | 0.02 | B0702 B3501 | 20 | RPRLFARAI | 0.01 | B0702 B3501 B5101 | 21 | ALYTSIPVR | 0.01 | A0301 A3101 | 22 | APALYTISL | 0.01 | B0702 B3501 | 23 | APNYYLTPL | 0.01 | B0702 B3501 | 24 | APAHGSVSL | 0.01 | B0702 B3501 | 25 | FVRVWDRSL | 0.01 | B0702 B0801 | 26 | STQPPVSSW | 0.01 | B5801 | 27 | LVHAGIAGK | 0.01 | A1101 A6801 | 28 | LTSAINQFW | 0.01 | B5801 | 29 | GTFAAPLRW | 0.01 | B5801 | 30 | AYFVVPLEM | 0.01 | A2402 | 31 | SPTPLLAAL | 0.01 | B0702 B3501 | 32 | TPSSARLSM | 0.01 | B0702 B3501 | 33 | MSLFVSTLF | 0.01 | B5801 | 34 | GYMPTASFK | 0.01 | A1101 | 35 | STVLRLFSF | 0.01 | B5801 | 36 | YLCDRTTAA | 0.01 | A0201 | 37 | NLAAGQSLK | <0.01 | A0301 | 38 | TMPTAPSSK | <0.01 | A0301 | 39 | VSGGSTVSF | <0.01 | B5801 | 40 | SAAAPYSLW | <0.01 | B5801 | 41 | RELQSVYLL | <0.01 | B4403 | 42 | SFDDYTMVL | <0.01 | A2402 | 43 | LFLLVIYAF | <0.01 | A2402 | 44 | RIKRNWQKK | <0.01 | A1101 | 45 | LLPRLFLAF | <0.01 | A0301 |
|
|